Design
Editorial
Authors
Loading...
This article highlights the resurgence of nuclear medicine through theranostics and advocates for individualized dosimetry and combination therapies in cancer care.
Key points are not available for this paper at this time.
J. Harvey Turner (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: